Rationale and Design of Two Trials Assessing the Efficacy, Safety, and Tolerability of Inclisiran in Adolescents with Homozygous and Heterozygous Familial Hypercholesterolaemia
European Journal of Preventive Cardiology(2022)
Key words
Hyperlipoproteinaemia type II,Cholesterol,LDL,Proprotein convertase 9,Inclisiran,RNA,Small interfering,Double-blind method,Paediatric,Adolescent
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined